Streptozocin for Injection 1 g Suppliers & Bulk Manufacturers
Available Forms: Lyophilised powder vial (IV)
Available Strengths: 1 g
Pack Sizes: Single vial
Reference Brands: Zanosar
Category: Oncology Cancer Care
Streptozocin 1 g injection (reference Zanosar) is an alkylating chemotherapy used mainly for pancreatic neuroendocrine tumours. Supply has been short in the US and other markets, so hospitals often need alternative or imported stock. PharmaTradz connects hospital, tender and distributor buyers with GMP-certified manufacturers and licensed exporters, and checks the documents needed for the destination market.
Manufacture or export Streptozocin for Injection? List it or send an offer →
Product Description:
Streptozocin is a nitrosourea chemotherapy that damages DNA in dividing cells. It is taken up strongly by the insulin-producing beta cells of the pancreas, which is why its main use is in pancreatic neuroendocrine tumours (islet cell tumours). It is usually combined with fluorouracil or doxorubicin and given by intravenous infusion in cycles.
The drug can harm the kidneys, so kidney function and urine protein are checked before each dose. It can also cause marked nausea and changes in blood sugar. Each 1 g vial is reconstituted and given in a specialist oncology setting.
Sourcing notes. Streptozocin is an old, off-patent medicine with very few manufacturers worldwide, and it has been on the US FDA shortage list. When local stock runs out, hospitals turn to imported product under shortage or special-import rules. We help buyers find GMP-certified sources, check the registration status in the exporting country and arrange the batch documents the importing authority asks for.
Streptozocin for Injection — third party manufacturing & bulk supply
Streptozocin for Injection 1 g is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Streptozocin for Injection is supplied as Lyophilised powder vial (IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Streptozocin for Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Streptozocin for Injection →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Mainly for advanced pancreatic neuroendocrine (islet cell) tumours, usually in combination with other chemotherapy.
Zanosar. It is supplied as a 1 g powder vial for intravenous use.
Very few companies make it, so any production problem quickly causes a shortage. It has been listed in short supply in the US.
Many regulators allow temporary or special import of an unregistered product during a shortage. We confirm the route for your country before quoting.
Related Products
Pegaspargase Injection
Strength:
3,750 IU/5 mL (750 IU/mL)
Form: Solution or lyophilised powder vial (IM/IV)
Reference Brands: Oncaspar
View DetailsGoserelin Implant
Strength:
3.6 mg (1-month), 10.8 mg (3-month)
Form: Implant in pre-filled syringe applicator (subcutaneous)
Reference Brands: Zoladex, Zoladex LA
View DetailsGedatolisib for Injection
Strength:
180 mg
Form: Powder vial (IV infusion)
Reference Brands: Revtorpyk
View DetailsEpirubicin Hydrochloride
Strength:
10 mg/5 mL, 50 mg/25 mL, 100 mg/50 mL, 200 mg/100 mL
Form: Injection (IV)
Reference Brands: Ellence® (US) , Farmorubicin®(EU)
View DetailsPalonosetron Injection
Strength:
0.25 mg/5 mL (0.05 mg/mL)
Form: IV Injection
Reference Brands: Aloxi (US & EU)
View DetailsRucaparib Camsylate
Strength:
200 mg, 250 mg, 300 mg
Form: Oral tablets
Reference Brands: Rubraca® (EU & US)
View DetailsRituximab
Strength:
IV infusion: 100 mg/10 mL, 500 mg/50 mL; SQ: 1400 mg/11 mL
Form: IV Infusion; Subcutaneous
Reference Brands: Rituxan®(US), MabThera® (EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit